IC
BHVN icon

Ikarian Capital’s Biohaven BHVN Stock Holding History

Ikarian Capital’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1M Buy
748,181
+335,700
+81% +$3.61M 1.2% 24
2026
Q1 		$3.49M Buy
412,481
+200,000
+94% +$2.19M 0.28% 77
2025
Q4 		$2.4M Buy
+212,481
New +$2.63M 0.19% 94
2023
Q4 		– Sell
-106,138
Closed -$2.76M – 144
2023
Q3 		$2.76M Sell
106,138
-321,279
-75% -$6.68M 0.33% 69
2023
Q2 		$10.2M Buy
427,417
+25,091
+6% +$432K 1.63% 21
2023
Q1 		$5.5M Sell
402,326
-435,174
-52% -$6.93M 1.25% 26
2022
Q4 		$11.6M Buy
+837,500
New +$11.8M 2.8% 8

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ikarian Capital's BHVN Position: Q2 2026 in Review

Ikarian Capital increased its Biohaven (BHVN) stake by 81% in Q2 2026, buying an estimated $3.61M and bringing the position to 748,181 shares worth $11.1M. The position accounts for 1.2% of the portfolio, ranked #24.

Ikarian Capital first reported a position in BHVN in Q4 2022 and has held it in 7 quarters since. The position peaked at $11.6M in Q4 2022. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Ikarian Capital held 748,181 shares of Biohaven worth $11.1M as of Q2 2026.
  • Ikarian Capital bought 335,700 Biohaven shares in Q2 2026, an estimated $3.61M.
  • Biohaven made up 1.2% of Ikarian Capital's portfolio in Q2 2026, its #24 holding.
  • Ikarian Capital first reported a position in Biohaven in Q4 2022 and has held it in 7 quarters since.
  • Ikarian Capital's Biohaven position peaked at $11.6M in Q4 2022.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.